<DOC>
	<DOC>NCT00337766</DOC>
	<brief_summary>Patients undergoing cardiac surgery could develop excessive perioperative bleeding requiring transfusions of blood products. Desmopressin (DDAVP), already used for patients with von Willebrand syndrome, could reduce bleeding and transfusion requirements in these patients when administered ev (0.3 mg/kg) in 20-30 minutes postoperatively.</brief_summary>
	<brief_title>Desmopressin in Cardiac Surgery</brief_title>
	<detailed_description />
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Blood Loss, Surgical</mesh_term>
	<mesh_term>Postoperative Hemorrhage</mesh_term>
	<mesh_term>Deamino Arginine Vasopressin</mesh_term>
	<criteria>undergoing cardiac surgery excessive bleeding age&lt;18 y not signing written consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>100 Years</maximum_age>
	<verification_date>May 2013</verification_date>
	<keyword>Blood Loss</keyword>
	<keyword>Postoperative Blood loss</keyword>
</DOC>